The North America Drug-Eluting Stent Market is experiencing significant growth driven by the increasing prevalence of cardiovascular diseases and the growing demand for advanced interventional cardiology procedures across the region. Rising incidences of coronary artery disease, an aging population, and increasing preference for minimally invasive treatment procedures are key...